Old Web
English
Sign In
Acemap
>
authorDetail
>
Yanli Xing
Yanli Xing
Guangzhou Institutes of Biomedicine and Health
Structure–activity relationship
Chemistry
Inverse agonist
Nuclear receptor
Drug Inverse Agonism
4
Papers
75
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Discovery and Characterization of Benzimidazole Derivative XY123 as a Potent, Selective, and Orally Available RORγ Inverse Agonist.
2021
Journal of Medicinal Chemistry
Wu Xishan
Hui Shen
Yan Zhang
Chao Wang
Qiu Li
Cheng Zhang
Xiaoxi Zhuang
Chenchang Li
Yudan Shi
Yanli Xing
Qiuping Xiang
Jinxin Xu
Donghai Wu
Jinsong Liu
Yong Xu
Show All
Source
Cite
Save
Citations (1)
Discovery of Benzo[cd]indol-2(1H)-ones as Potent and Specific BET Bromodomain Inhibitors: Structure-Based Virtual Screening, Optimization, and Biological Evaluation
2016
Journal of Medicinal Chemistry
Xiaoqian Xue
Yan Zhang
Zhaoxuan Liu
Ming Song
Yanli Xing
Qiuping Xiang
Zhen Wang
Zhengchao Tu
Yulai Zhou
Ke Ding
Yong Xu
Show All
Source
Cite
Save
Citations (55)
Discovery and structural optimization of 4-(4-(benzyloxy)phenyl)-3,4-dihydropyrimidin-2(1H)-ones as RORc inverse agonists
2016
Acta Pharmacologica Sinica
Xi-shan Wu
Rui Wang
Yanli Xing
Xiaoqian Xue
Yan Zhang
Yong-Zhi Lu
Yu Song
Xiao-yu Luo
Chun Wu
Yulai Zhou
Jian-Qin Jiang
Yong Xu
Show All
Source
Cite
Save
Citations (8)
Identification of N -phenyl-2-(N -phenylphenylsulfonamido)acetamides as new RORγ inverse agonists: Virtual screening, structure-based optimization, and biological evaluation
2016
European Journal of Medicinal Chemistry
Yu Song
Xiaoqian Xue
Xishan Wu
Rui Wang
Yanli Xing
Weiqun Yan
Yulai Zhou
Chao Nan Qian
Yan Zhang
Yong Xu
Show All
Source
Cite
Save
Citations (11)
1